@brianmackenna.bsky.social
Pharmacist | MPH | Data
@brianmackenna.bsky.socialWe are hosting a conference on Open Code in Science in Oxford.
The magnificent @doctorow.pluralistic.net will be giving the closing keynote!
It will be FREE to attend in Oxford in the beautiful exam schools.
More details and booking 👇
@shinyblackshoe.bsky.socialReposted by @brianmackenna.bsky.socialAre you wanting to track your SC switch progress against your peers? 👇🏻👇🏻👇🏻
@brianmackenna.bsky.socialImo they should focus on making the data available as this would reduce reliance on one organisation having staff available
My 5k words on it
@brianmackenna.bsky.socialA nice monthly updating chart here of regional variation
@brianmackenna.bsky.socialHave you got an link to/ image of the poster ? We've been looking closely at pembrolizumab_sc recently
@brianmackenna.bsky.socialI think we got some of the way there during the pandemic with assembling national data on high cost cancer drugs
pubmed.ncbi.nlm.nih.gov/35634533/
But we've regressed. So def better done once.....but its hard !
@brianmackenna.bsky.socialThings that use meds data that we can maybe learn from for OpenPrescribing or OpenSAFELY, implement new measures and/or collaborate !
@brianmackenna.bsky.socialWill they all be online at some stage ?
@brianmackenna.bsky.socialNot even his most incisive take of the week.....ruined traitors for me tonight
@brianmackenna.bsky.socialReposted by @brianmackenna.bsky.socialMore from @news.rte.ie on the Irish health service's growing use of opioids.
I wrote about this on Linkedin earlier this year
@brianmackenna.bsky.socialMore from @news.rte.ie on the Irish health service's growing use of opioids.
I wrote about this on Linkedin earlier this year
@brianmackenna.bsky.socialReposted by @brianmackenna.bsky.socialRespiratory Folk
New AIR/MART inhaler measure to monitor the impact of the changes introduced in the BTS/NICE/SIGN asthma guideline across English general practices and hospitals
Audit your organisations progress!
@brianmackenna.bsky.socialRespiratory Folk
New AIR/MART inhaler measure to monitor the impact of the changes introduced in the BTS/NICE/SIGN asthma guideline across English general practices and hospitals
Audit your organisations progress!
@brianmackenna.bsky.socialHave you any recommendations for a single article that I could read to get a gist of the scandals ?
@bennettoxford.bsky.socialReposted by @brianmackenna.bsky.socialFor #WorldPatientSafetyDay, we’re highlighting two OpenPrescribing measures that help NHS teams examine the prescribing of oral morphine solution.
🔍Explore the measures:
https://openprescribing.net/measure/morphine_solution_list/
https://openprescribing.net/measure/morphine_solution_high_quantity/
@phcsg.bsky.socialReposted by @brianmackenna.bsky.social🚨 Our speaker line-up is shaping up to be something special!
Hear from Prof. Ben Goldacre, Brian MacKenna, Dr Anne-Marie Cunningham, Prof. Tony Avery, Prof. Simon de Lusignan & Dr Neil Paul at the BCS PHCSG Annual Conference & Education Day 2026.
12-13 November - Oxford
@brianmackenna.bsky.socialReposted by @brianmackenna.bsky.social🧵 1/6 📢 New on OpenPrescribing-Hospitals: subcutaneous pembrolizumab
hospitals.openprescribing.net/measures/pem...
We’ve rapidly added a new measure so you can see how every NHS hospital is getting on with the rollout of rapid pembrolizumab injections.
@brianmackenna.bsky.social6/6 We hope NHS teams use it to compare trusts, spot where adoption is faster and share practical solutions. We shipped this in the first month of the programme because it’s what users needed. Need routine measures for your hospital medicines programme? Shout at us! 📣 (Or politely email)
@brianmackenna.bsky.socialThe NHS has published its May hospital medicines data. We’ve rapidly implemented a new OpenPrescribing-Hospitals measure showing adoption of subcutaneous pembrolizumab. You can explore it by hospital, ICB, region and nationally
@brianmackenna.bsky.socialI say potentially because announcing a rollout and actually making it happen across the NHS are two different things… 😬
(More on implementation of cancer treatments another time!)
But now we can actually see how the rollout is going.